NEW YORK (GenomeWeb News) – A pair of investment banks today upgraded Affymetrix’s stock one day after a court found its principal rival Illumina guilty of infringing five of its patents.
 
News of the verdict, which forced Illumina to pay Affy $16.7 million in royalties for past sales, continued to buoy Affy’s shares, which were up 6.5 percent, or $1.70, at $28.31 in mid-afternoon trading today.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.